Psychedelic Drugs as Therapeutics: No Illusions About the Challenges
Edward M. Sellers, Deborah B. Leiderman
Clinical Pharmacology & Therapeutics August 24, 2017 DOI: 10.1002/cpt.776 via OpenAlex
Summary
AI-generated from the abstractInterest in the potential therapeutic benefits of psychedelic agents has recently increased. Besides psilocybin, many other agents with psychedelic properties have been proposed and partially tested. However, obtaining approval to market a restricted psychotomimetic agent faces formidable challenges.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Psychotomimetic Hallucinogen Illusion Variety cybernetics |
| Citations | 27 |
| Key finding | Obtaining approval to market a restricted psychotomimetic agent is formidable. |
Abstract
Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.